Study of the Use of Antinematode Drugs, Mebendazole and Pyrantel, in Galicia (Spain) from 2016 to 2020

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left"></td><td class="align_center">Spring</td><td class="align_center">Summer</td><td class="align_center">Fall</td><td class="align_center">Winter</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">Mebendazole</td><td class="align_center">0.031</td><td class="align_center">0.030</td><td class="align_center">0.036</td><td class="align_center">0.033</td></tr><tr><td class="align_left">Pyrantel</td><td class="align_center">0.004</td><td class="align_center">0.003</td><td class="align_center">0.004</td><td class="align_center">0.005</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Mean value of the defined daily dose per 1000 inhabitants and day (DHD) of mebendazole and pyrantel in each season (2016–2020).</div>

Journal of Parasitology Research

tab2

Table 2

Table 2: Study of the Use of Antinematode Drugs, Mebendazole and Pyrantel, in Galicia (Spain) from 2016 to 2020 